CME Group Inc. (NASDAQ:CME) has been given a consensus recommendation of “Hold” by the fourteen analysts that are presently covering the stock. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating on the company. The average 1-year target price among analysts that have covered the stock in the last year is $101.88.

A number of equities analysts have commented on CME shares. Royal Bank Of Canada reduced their target price on CME Group from $97.00 to $92.00 and set an “underperform” rating for the company in a report on Friday, October 28th. Deutsche Bank AG increased their target price on CME Group from $115.00 to $116.00 and gave the company a “buy” rating in a report on Wednesday, October 5th. Jefferies Group increased their target price on CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a report on Wednesday, August 31st. JPMorgan Chase & Co. set a $116.00 target price on CME Group and gave the company a “buy” rating in a report on Monday, September 12th. Finally, RBC Capital Markets set a $92.00 target price on CME Group and gave the company a “sell” rating in a report on Friday, October 28th.

CME Group (NASDAQ:CME) opened at 113.93 on Wednesday. CME Group has a 12-month low of $81.87 and a 12-month high of $117.80. The company’s 50-day moving average price is $105.90 and its 200-day moving average price is $102.10. The stock has a market cap of $38.66 billion, a PE ratio of 26.56 and a beta of 0.81.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, October 27th. The company reported $1.05 EPS for the quarter, beating analysts’ consensus estimates of $1.04 by $0.01. CME Group had a return on equity of 6.90% and a net margin of 41.54%. The business earned $842 million during the quarter, compared to analysts’ expectations of $855.94 million. During the same quarter in the prior year, the firm earned $1.02 earnings per share. The business’s revenue was down 1.0% compared to the same quarter last year. On average, equities analysts expect that CME Group will post $4.35 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 28th. Stockholders of record on Friday, December 9th will be given a dividend of $0.60 per share. The ex-dividend date is Wednesday, December 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.11%. CME Group’s dividend payout ratio is currently 55.94%.

In related news, Director Dennis Suskind sold 2,000 shares of CME Group stock in a transaction on Wednesday, November 2nd. The stock was sold at an average price of $100.52, for a total value of $201,040.00. Following the completion of the transaction, the director now directly owns 8,499 shares in the company, valued at $854,319.48. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Kimberly S. Taylor sold 2,300 shares of CME Group stock in a transaction on Tuesday, August 30th. The shares were sold at an average price of $107.16, for a total value of $246,468.00. Following the completion of the transaction, the insider now owns 101,489 shares of the company’s stock, valued at $10,875,561.24. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CME. Vanguard Group Inc. raised its position in CME Group by 2.1% in the second quarter. Vanguard Group Inc. now owns 20,131,757 shares of the company’s stock worth $1,960,833,000 after buying an additional 406,686 shares during the period. Capital International Investors raised its position in CME Group by 1.8% in the second quarter. Capital International Investors now owns 11,079,915 shares of the company’s stock worth $1,079,184,000 after buying an additional 197,881 shares during the period. BlackRock Institutional Trust Company N.A. raised its position in CME Group by 0.3% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 10,124,205 shares of the company’s stock worth $1,058,182,000 after buying an additional 31,832 shares during the period. BlackRock Fund Advisors raised its position in CME Group by 4.3% in the third quarter. BlackRock Fund Advisors now owns 9,464,800 shares of the company’s stock worth $989,261,000 after buying an additional 391,783 shares during the period. Finally, JPMorgan Chase & Co. raised its position in CME Group by 1.3% in the third quarter. JPMorgan Chase & Co. now owns 7,064,945 shares of the company’s stock worth $738,427,000 after buying an additional 88,456 shares during the period. Hedge funds and other institutional investors own 80.60% of the company’s stock.

About CME Group

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.